ArticleScientific reports2024

Clinically-observed FOXA1 mutations upregulate SEMA3C through transcriptional derepression in prostate cancer.

Kevin J Tam et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.